2016
Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults
Gebistorf F, Karam O, Wetterslev J, Afshari A. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Of Systematic Reviews 2016, 2018: cd002787. PMID: 27347773, PMCID: PMC6464789, DOI: 10.1002/14651858.cd002787.pub3.Peer-Reviewed Original ResearchConceptsAcute respiratory distress syndromeAcute hypoxaemic respiratory failureTrial sequential analysisEffects of iNORespiratory distress syndromeINO groupControl groupDistress syndromeNitric oxideRisk ratioSecondary objectiveHypoxaemic respiratory failureTrial methodological componentsVentilator-free daysCochrane Central RegisterPrimary outcome measureEffect of administrationLength of stayRisk of biasConfidence intervalsAllied Health LiteratureSearch of MEDLINELevel of evidenceEffects of interventionsNitric oxide results
2007
VGAM induced high-flow congestive heart failure responsive to PGE1 infusion
Karam O, da Cruz E, Rimensberger PC. VGAM induced high-flow congestive heart failure responsive to PGE1 infusion. International Journal Of Cardiology 2007, 132: e60-e62. PMID: 18022260, DOI: 10.1016/j.ijcard.2007.08.020.Peer-Reviewed Original ResearchMeSH KeywordsAlprostadilBlood Flow VelocityHeart FailureHumansInfant, NewbornInfusions, IntravenousMaleVasodilator AgentsVein of Galen MalformationsConceptsCongestive heart failurePersistent pulmonary hypertensionPulmonary hypertensionHeart failurePGE1 infusionAdequate systemic blood flowCardiac failure refractoryRefractory cardiac failureSuprasystemic pulmonary hypertensionProstaglandin E1 infusionMassive intracerebral hemorrhageSystemic blood flowTerm male infantMain therapeutic strategiesNormal cardiac anatomyRare congenital anomalyCardiogenic shockDuctal shuntingInotropic drugsPercutaneous occlusionCardiac failureIntracerebral hemorrhageMechanical ventilationVolume overloadDiastolic overload